Default company panoramic image
B619d42d 875a 4de4 94c3 f9c0d4e4ccdb

Heterogenous Nanosystems

Building a platform for the next generation of biologics

  • Stage Not Set
  • Industry Biotechnology
  • Location Halifax, NS, Canada
  • Currency CAD

Company Summary

The company will hold the IP. The IP will hold a central stake in the future of personalized medicine. The customers will be developed through licensing agreements or, more preferably, the company will be sold through M&A to "Big Pharma" upon concept validation.